HOS from proteolysis. Taken together, our data suggest that proteolysis of HOS depends on its interaction with active components of the SCF complex and that HOS stability is regulated by a bound substrate. These findings may define a mechanism for maintaining activities of specific SCF complexes based on availability of a particular substrate.
Introduction
E3 ubiquitin protein ligases determine specificity and timing of the ubiquitin-dependent proteolysis that plays a key role in regulating the activities of many proteins. Both recognition of a substrate and catalysis of ubiquitin transfer are the major functions of ubiquitin ligases that can be conferred by different domains of a single protein (e.g., Mdm2, Nedd4) or different proteins within a complex enzyme (e.g., SCF, CBC VHL , APC, etc.; reviewed in (1)).
The modular features of complex ubiquitin ligases offer the biological advantages of expanded substrate specificity and rapid switching between various substrates to satisfy a cell's demand for ligase activity toward a particular substrate. However, an important mechanism regulating disassembly of existing complexes and assembly of new ones must be in place to allow rapid switching. Ubiquitination and degradation of ligase receptors that actually recognize specific substrates may enable the core ligase components to recruit different types of receptors to mediate such a mechanism.
F-box proteins serve as receptors for the SCF (Skp1-Cul1-F-box protein) E3 ligases family, whose members ubiquitinate specifically phosphorylated substrates and play a key role in the regulation of the cell cycle, signal transduction and transcriptional activation (reviewed in (2)). F-box proteins contain WD40-or leucine-rich repeat domains that interact with phosphorylated substrates as well as an F-box motif, which is required for binding to Skp1 (3) . Skp1 tethers F-box proteins to the core ligase complex consisting of Cdc53/Cullin1 and Roc1/Rbx1, which, in turn, recruits an E2 ubiquitin-conjugating enzyme and mediates substrate ubiquitination (reviewed in (2) ).
the absence of a substrate, an F-box protein ubiquitination requires such release remains to be determined.
Two opposite models could be envisioned to address a major question regarding a potential role for substrate availability in regulating the F-box protein stability. One of these models favors co-ubiquitination of an F-box protein together with a bound substrate, predicting that, in the absence of substrate, stabilization of an F-box protein may occur.
Another model proposes that a substrate would shield an F-box protein from ubiquitination by core components of the SCF ligase (2) . Experimental evidence supporting either of these models has not been reported.
In this study, we sought to investigate the role of SCF ligase and the availability of a substrate in regulating the stability of the HOS F-box protein. HOS (also termedTrCP2/Fbw1b) serves as a receptor of the mammalian SCF HOS E3 ubiquitin ligase to mediate ubiquitination and degradation of phosphorylated I B and -catenin and regulate NF-B and -catenin signaling pathways (19) . Mechanisms determining the abundance of HOS play an important role in regulating these signaling cascades and, in turn, in modulating cell differentiation and malignant transformation (20, 21) .
We show that the integrity of the F-box of HOS and the activity of Cullin-based ligases are essential for ubiquitination and degradation of HOS. HOS is ubiquitinated within the SCF HOS complex in vitro, and addition of phosphorylated I B inhibits this process. Moreover, stimuli that increase the levels of phosphorylated I B in cells stabilize HOS and increase its levels. These data provide an insight into the potential contribution of mechanisms regulating HOS stability in satisfying the cellular demands for continuous activity of the SCF HOS E3 ubiquitin ligase.
Experimental Procedures
DNA constructs. The pCDNA3-based construct for expression of HA-tagged HOS was previously described (19) . HOS cDNA was sub-cloned into pEF-HA vector (a gift from E.
Spanopoulou) and PCR-mediated mutagenesis was used to delete the cDNA sequence encoding HOS F-box (amino acids 117-169). Vectors for mammalian expression of Flag- Tissue culture and transfections. Human 293T human embryo kidney cells and normal human fibroblasts (TIG, a gift from H. Tahara) were grown in Dulbecco-modified Eagle's medium (DMEM) in the presence of 10% fetal bovine serum and antibiotics at 37ºC and 5% CO 2 . Hamster CHO-K1 and ts41 cells (a gift from R. Neve) were grown in DMEM supplemented with 10% calf serum, antibiotics and fungizone (0.625 g/ml, Invitrogen) at 34ºC and 5% CO 2 . These cells were shifted to 40ºC 24h before harvesting where indicated.
Transfections were performed using the calcium phosphate procedure or Lipofectamine Plus (Invitrogen) at 24-48h before harvesting. For cell treatment, Actinomycin D, sodium salicylate, and cycloheximide (Sigma), as well as neocarzinostatin (NCS, Kayaku Co. Tokyo, Japan), were purchased and used at indicated concentrations.
Antibodies and immunological techniques
Antibodies against HA (Roche), -tubulin and Flag M2 (Sigma), and I B (phospho-serine 32-specific, Santa Cruz) were purchased.
Antibody against HOS (HOS-N) was previously described (27) . Secondary antibodies conjugated with horseradish peroxidase (Amersham) were purchased. Immunoprecipitation and immunoblotting analyses were described elsewhere (19) . Figure 4A) by Coomassie staining. The SCR complex, derived from 50 l of bacterial extracts and immobilized to glutathione beads, was assayed for ubiquitin ligase activity as previously described (28) . Briefly, this complex was incubated with 32 P-labeled ubiquitin (1 g), E1
(20pmol), E2 (Cdc34 or UbcH5c, 100pmol) and ATP (2mM) in the presence of ubiquitination buffer (50mM Tris-HCl, pH 7.4, 5mM MgCl 2 , 2mM NaF, 10nM okadaic acid) in a 20 l total volume at 37ºC for 60min. Formation of ubiquitin chains was analyzed by autoradiography.
To prepare mammalian SCR, plasmids for expression of Flag-tagged Cullin1, Roc1 and Skp1 were transfected into 293T cells, and the entire complex was purified with immobilized Flag antibody (M2, Sigma).
For assessment of in vitro HOS ubiquitination, in vitro-translated and 35 S-methioninelabeled HOS was captured on immobilized SCR, washed with A-500 buffer (25mM Tris-HCl, pH7.4, 0.5M NaCl, 0.25% NP-40, 10% glycerol), re-equilibrated with ubiquitination buffer and subjected to the ubiquitination reaction with recombinant E1 and E2 as indicated above.
Phosphorylated by IKK (as described earlier (28)) or non-phosphorylated GST-I B ,
proteins (25pmol) were added prior to the start of the reaction as indicated. Products of the reactions were separated on SDS-PAGE and analyzed by autoradiography.
Results

HOS is ubiquitinated in cells and undergoes proteasome-dependent degradation.
We sought to investigate whether HOS undergoes ubiquitination and degradation in cells.
293T cells were co-transfection of HA-tagged HOS with hexahistidine-tagged ubiquitin and harvested. Immunoblotting analysis of ubiquitinated proteins purified on nickel resins under denaturing conditions (25) revealed slower migrating HA-reactive species as a smear at the top of the gel. These species were not observed when either HA-HOS of his-ubiquitin plasmids were omitted from transfection ( Figure 1A ). These data indicate that HOS is covalently conjugated with ubiquitin in vivo under these experimental conditions.
Previous findings demonstrate that treatment of cells with inhibitors of 26S proteasome results in accumulation of recombinant HOS (19) . We assessed the effect of proteasome inhibition on the rate of HOS proteolysis by pulse chase analysis. Recombinant HOS was To exclude the possibility that inhibition of HOS degradation is a general characteristic of hamster cells exposed to 40ºC, we carried out a similar experiment in Chinese hamster ovarian (CHO) cells, which harbor wild type APP-BP1 (33) . In this cell line HOS degraded at 34ºC (although less efficiently than in ts41 cells, most likely because of the genetic differences between epithelial CHO cells and ts41 fibroblasts). However, HOS degradation was accelerated in CHO cells grown at 40ºC ( Figure 3A ).
We further focused our analysis at the levels of endogenous HOS in ts41 cells. 
Activation of I B kinase (IKK) inhibits ubiquitination and degradation of HOS.
We next sought to determine whether increasing the levels of a substrate (e.g., phospho-I B)
would affect HOS ubiquitination in cells. I B is phosphorylated within the HOS recognition motif by IKK, which is induced by various inflammatory cytokines and stress stimuli (36) .
We chose to use a constitutively active IKK S177,181E mutant known to efficiently phosphorylate I B in vivo (19, 24) . Figure   5C ). This result excludes the possibility that stabilization of HOS is indirectly mediated by the products of NF-B target genes. In all, these data suggest that in the presence of a phosphorylated substrate, HOS is protected from ubiquitination and subsequent degradation. 
Discussion
The data presented here show that HOS stability is regulated via the ubiquitin-proteasome pathway ( Figure 1 ). Ubiquitination and degradation of HOS depends on the integrity of its Fbox motif (Figure 2 ) and the activity of Cullin-based E3 ligases ( (44)), is stabilized via interaction with hRNP-U protein, which does not interact with HOS (45) . Since -TrCP1 is closely related to HOS, it is conceivable that, in addition to hRNP-U effects, interaction of phosphorylated substrates with -TrCP1 may also contribute to stabilization of this F-box protein.
Activation of the NF-B pathway, which depends on IKK activation (reviewed in (36)) and HOS/ -TrCP1-mediated ubiquitination and degradation of I B (19, 44) , is a key mechanism underlying the cell's ability to cope with stress (36, 46) . HOS activities are 
